Order Article Reprints

Hofmann M, Kunte SC, Unterrainer M, Delker A, Holzgreve A, Toms J, Gildehaus FJ, Auernhammer CJ, Spitzweg C, Zacherl MJ, et al. Comparison of the Hematotoxicity of PRRT with Lutathera^® and Locally Manufactured ¹⁷⁷Lu-HA-DOTATATE in Patients with Neuroendocrine Tumors and the Impact of Different Application Intervals. Cancers. 2025; 17(9):1423. https://doi.org/10.3390/cancers17091423

Hofmann, Markus, Sophie C. Kunte, Marcus Unterrainer, Astrid Delker, Adrien Holzgreve, Johannes Toms, Franz Joseph Gildehaus, Christoph J. Auernhammer, Christine Spitzweg, Mathias J. Zacherl, and et al. 2025. "Comparison of the Hematotoxicity of PRRT with Lutathera^® and Locally Manufactured ¹⁷⁷Lu-HA-DOTATATE in Patients with Neuroendocrine Tumors and the Impact of Different Application Intervals" Cancers 17, no. 9: 1423. https://doi.org/10.3390/cancers17091423

Hofmann, M., Kunte, S. C., Unterrainer, M., Delker, A., Holzgreve, A., Toms, J., Gildehaus, F. J., Auernhammer, C. J., Spitzweg, C., Zacherl, M. J., Ilhan, H., Rübenthaler, J., Beyer, L., & Unterrainer, L. M. (2025). Comparison of the Hematotoxicity of PRRT with Lutathera^® and Locally Manufactured ¹⁷⁷Lu-HA-DOTATATE in Patients with Neuroendocrine Tumors and the Impact of Different Application Intervals. Cancers, 17(9), 1423. https://doi.org/10.3390/cancers17091423